US Patent Issued to EDGEWISE THERAPEUTICS on Feb. 24 for "Quinazolinone dione compounds and uses thereof" (Colorado, Washington, Connecticut Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,464, issued on Feb. 24, was assigned to EDGEWISE THERAPEUTICS INC. (Boulder, Colo.).

"Quinazolinone dione compounds and uses thereof" was invented by Natalie Anne Hawryluk (Nederland, Colo.), Stephen Thomas Schlachter (Boulder, Colo.), Kevin Koch (Niwot, Colo.), Michael Joseph Luzzio (Groton, Conn.), Michael Mark Duvall (Vancouver, Wash.), Alan James Russell (Boulder, Colo.), Marc Justin Evanchik (Boulder, Colo.) and Kevin Hunt (Boulder, Colo.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are quinazolinone dione compounds for treating cardiac indications such as hypertrophic cardiomyopathy and diastolic dysfunction."

The patent was filed ...